EA produces concurrent analgesic and antidepressant effects by modulating the CREB-serotonin-BDNF signaling axis in the anterior cingulate cortex and spinal cord regions in murine models of chronic neuropathic pain comorbidity with depression-like behaviors.[165]. This evidence concerns the gene CREB1 and depressive symptom measurement.